1. Scheinberg DA, Lovett D, Divgi DR, et al.: A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol 1991, 9:478–490.
2. Caron PC, Co MS, Bull MK, et al.: Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies. Cancer Res 1992, 148:6761–6767.
3. Caron PC, Jurcic JG, Scott AM, et al.: A phase IB trial of humanized antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity. Blood 1994, 83:1760–1768.
4. Xu Y, Scheinberg DA: Elimination of human leukemia by monoclonal antibodies in an athymic nude mouse model. Clin Cancer Res 1995, 1:1179–1187.
5. Caron PC, Dumont L, Scheinberg DA: Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia. Clin Cancer Res 1998, 4:1421–1428. See annotation below.